亚洲成a∨人片在无码_人与嘼在线观看_日日干婷婷影院天天干_麻豆av深夜在线观看

<abbr id="tgk83"><mark id="tgk83"></mark></abbr>

<sup id="tgk83"><button id="tgk83"></button></sup>

Beihai Biotech announced that its innovative cancer drug, BH009 (marketed as BEIZRAY), has received approval from the U.S. Food and Drug Administration (FDA)

2024-10-31
U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY?)

2024-01-04
Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School

2023-12-26
Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates

2023-12-19
Beihai Biotech Listed Among "Top 100 High-Growth Enterprises in the Greater Bay Area 2023"

2023-11-09
Innovation Recognized Again: Beihai Biotech Honored with GHP “Most Innovative Clinical-Stage Biopharmaceutical Company 2023”

2023-08-01
Beihai Biotech Secures “Drug Manufacturing Certificate”

2023-06-15
Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023

2023-06-12

Contact Information

Company address：Blg 2, No. 6366, Zhuhai Ave., Jinwan, Zhuhai, 519090, China
Tel：0756-6349669
Human resources contact：hr@bayhibiotech.com
Business cooperation contact：hjiang@bayhibiotech.com

: Wechat Official Account